These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 33367937)

  • 1. Drug Delivery Strategies to Overcome the Blood-Brain Barrier (BBB).
    Helms HCC; Kristensen M; Saaby L; Fricker G; Brodin B
    Handb Exp Pharmacol; 2022; 273():151-183. PubMed ID: 33367937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large amino acid transporter 1 (LAT1) prodrugs of valproic acid: new prodrug design ideas for central nervous system delivery.
    Peura L; Malmioja K; Laine K; Leppänen J; Gynther M; Isotalo A; Rautio J
    Mol Pharm; 2011 Oct; 8(5):1857-66. PubMed ID: 21770378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases.
    Löscher W; Potschka H
    Prog Neurobiol; 2005 May; 76(1):22-76. PubMed ID: 16011870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Multi-disciplinary research approaches on the brain barrier transport system, a dynamic interface].
    Tachikawa M; Uchida Y; Terasaki T
    Brain Nerve; 2013 Feb; 65(2):121-36. PubMed ID: 23399670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood-brain barrier transporters: a translational consideration for CNS delivery of neurotherapeutics.
    Ronaldson PT; Davis TP
    Expert Opin Drug Deliv; 2024; 21(1):71-89. PubMed ID: 38217410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small molecular drug transfer across the blood-brain barrier via carrier-mediated transport systems.
    Tsuji A
    NeuroRx; 2005 Jan; 2(1):54-62. PubMed ID: 15717057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Physiological function of blood-brain barrier transporters as the CNS supporting and protecting system].
    Ohtsuki S
    Yakugaku Zasshi; 2004 Nov; 124(11):791-802. PubMed ID: 15516806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood-brain barrier endogenous transporters as therapeutic targets: a new model for small molecule CNS drug discovery.
    Pardridge WM
    Expert Opin Ther Targets; 2015; 19(8):1059-72. PubMed ID: 25936389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transporter-mediated permeation of drugs across the blood-brain barrier.
    Tamai I; Tsuji A
    J Pharm Sci; 2000 Nov; 89(11):1371-88. PubMed ID: 11015683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood-Brain Barrier (BBB)-Crossing Strategies for Improved Treatment of CNS Disorders.
    Zhang W
    Handb Exp Pharmacol; 2024; 284():213-230. PubMed ID: 37528323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Membrane Transporters and Their Regulatory Mechanisms at the Brain and Retinal Barriers to Establish Therapies for Refractory Central Nervous System Diseases].
    Akanuma SI
    Yakugaku Zasshi; 2020; 140(10):1235-1242. PubMed ID: 32999202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Transporters for Drug Delivery to the Brain: Can We Do Better?
    Puris E; Fricker G; Gynther M
    Pharm Res; 2022 Jul; 39(7):1415-1455. PubMed ID: 35359241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New aspects of the blood-brain barrier transporters; its physiological roles in the central nervous system.
    Ohtsuki S
    Biol Pharm Bull; 2004 Oct; 27(10):1489-96. PubMed ID: 15467183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membrane transporter proteins: a challenge for CNS drug development.
    Girardin F
    Dialogues Clin Neurosci; 2006; 8(3):311-21. PubMed ID: 17117613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transporters at CNS barrier sites: obstacles or opportunities for drug delivery?
    Sanchez-Covarrubias L; Slosky LM; Thompson BJ; Davis TP; Ronaldson PT
    Curr Pharm Des; 2014; 20(10):1422-49. PubMed ID: 23789948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcellular brain drug delivery: A review on recent advancements.
    Azarmi M; Maleki H; Nikkam N; Malekinejad H
    Int J Pharm; 2020 Aug; 586():119582. PubMed ID: 32599130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of carrier-mediated transport systems to the blood-brain barrier as a supporting and protecting interface for the brain; importance for CNS drug discovery and development.
    Ohtsuki S; Terasaki T
    Pharm Res; 2007 Sep; 24(9):1745-58. PubMed ID: 17619998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular mechanisms of drug influx and efflux transport at the blood-brain barrier].
    Ohtsuki S; Hori S; Terasaki T
    Nihon Yakurigaku Zasshi; 2003 Jul; 122(1):55-64. PubMed ID: 12843573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human induced pluripotent stem cells (BIONi010-C) generate tight cell monolayers with blood-brain barrier traits and functional expression of large neutral amino acid transporter 1 (SLC7A5).
    Goldeman C; Andersen M; Al-Robai A; Buchholtz T; Svane N; Ozgür B; Holst B; Shusta E; Hall VJ; Saaby L; Hyttel P; Brodin B
    Eur J Pharm Sci; 2021 Jan; 156():105577. PubMed ID: 33011235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-Type Amino Acid Transporter 1 Enables the Efficient Brain Delivery of Small-Sized Prodrug across the Blood-Brain Barrier and into Human and Mouse Brain Parenchymal Cells.
    Montaser AB; Järvinen J; Löffler S; Huttunen J; Auriola S; Lehtonen M; Jalkanen A; Huttunen KM
    ACS Chem Neurosci; 2020 Dec; 11(24):4301-4315. PubMed ID: 33228353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.